Abstract
Postpartum psychosis is a rare but serious psychiatric illness that follows delivery. Although controversy continues to surround its diagnostic status, it is generally considered an episode of bipolar disorder with accompanying psychotic features. The consequences of untreated postpartum psychosis can be serious due to the associated risk of suicide and infanticide; however, its close temporal association with childbirth should provide an opportunity to undertake prophylactic measures in women at risk for developing postpartum psychosis. This article reviews the literature concerning acute and prophylactic pharmacological treatment and suggests a comprehensive approach for management of postpartum psychosis.
Keywords: Pregnancy, postpartum psychosis, bipolar disorder, pharmacotherapy and lactation
Current Drug Safety
Title: Treatment of Postpartum Psychosis: Challenges and Opportunities
Volume: 3 Issue: 1
Author(s): Verinder Sharma
Affiliation:
Keywords: Pregnancy, postpartum psychosis, bipolar disorder, pharmacotherapy and lactation
Abstract: Postpartum psychosis is a rare but serious psychiatric illness that follows delivery. Although controversy continues to surround its diagnostic status, it is generally considered an episode of bipolar disorder with accompanying psychotic features. The consequences of untreated postpartum psychosis can be serious due to the associated risk of suicide and infanticide; however, its close temporal association with childbirth should provide an opportunity to undertake prophylactic measures in women at risk for developing postpartum psychosis. This article reviews the literature concerning acute and prophylactic pharmacological treatment and suggests a comprehensive approach for management of postpartum psychosis.
Export Options
About this article
Cite this article as:
Sharma Verinder, Treatment of Postpartum Psychosis: Challenges and Opportunities, Current Drug Safety 2008; 3 (1) . https://dx.doi.org/10.2174/157488608783333961
DOI https://dx.doi.org/10.2174/157488608783333961 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimer's disease: Targeting the Cholinergic System
Current Neuropharmacology Current Concepts Underlying Benefits of Exercise Training in Congestive Heart Failure Patients
Current Cardiology Reviews Neuroprotective Mechanisms as Treatment Strategy in Alzheimers disease
Current Medicinal Chemistry - Central Nervous System Agents Application of In Vivo Animal Models to Characterize the Pharmacokinetic and Pharmacodynamic Properties of Drug Candidates in Discovery Settings
Combinatorial Chemistry & High Throughput Screening Cholecystokinin Antagonists A New Way to Improve the Analgesia from Old Analgesics?
Current Pharmaceutical Design Steroid Receptor Ligands for Breast Cancer Targeting: An Insight into Their Potential Role As Pet Imaging Agents
Current Medicinal Chemistry Potential Use of Vanadium Compounds in Therapeutics
Current Medicinal Chemistry PP2A and Alzheimer Disease
Current Alzheimer Research Phytochemical Composition, Pharmacological Properties, and Therapeutic Applications of Celastrus paniculatus
Current Traditional Medicine Drug Screening for Huntingtons Disease and other Neurodegenerative Disorders
Current Molecular Pharmacology Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
Current Pharmaceutical Design Sleep, Depression and Insomnia – A Vicious Circle?
Current Psychiatry Reviews Novel Kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design
Current Pharmaceutical Design How Does the Covıd-19 Pandemıc Affect the Target 90-90-90?
Current HIV Research Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?
CNS & Neurological Disorders - Drug Targets In Vitro Evidence for Competitive TSPO Binding of the Imaging Biomarker Candidates Vinpocetine and Two Iodinated DAA1106 Analogues in Post Mortem Autoradiography Experiments on Whole Hemisphere Human Brain Slices
Current Radiopharmaceuticals Adult Neurogenesis: Can Analysis of Cell Cycle Proteins Move Us “Beyond BrdU”?
Current Pharmaceutical Biotechnology Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Can Bioinformatic Methods Inform Us About the Molecular Evolution of Different Human Caspases?
Current Bioinformatics Research Progress of Essential Oil as a New Complementary Therapy in the Treatment of Depression
Mini-Reviews in Medicinal Chemistry